Analysts are piling on the praise for Vertex Pharmaceuticals, reaffirming bullish ratings even as the stock slightly fumbles ...

Vertex Pharmaceuticals (VRTX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...

Ever wondered what the world would be like if insects were as big as elephants or weasels were the size of humans? It gets pretty weird. You can read more about why giant prehistoric animals got ...

Vertex Pharmaceuticals got a healthy boost on Tuesday, with shares climbing nearly 3% thanks to a double dose of analyst ...

Vertex Pharmaceuticals (NASDAQ: VRTX) had a fine Tuesday on the stock exchange. The biotech's shares closed the day nearly 3% ...

In the default model, the graph representing each individual enhancer can be arbitrarily complicated. To show how the ABC Score formula can arise from the default model, we need to impose the further ...

Vertex reported revenues of $2.91 billion in the last reported quarter, representing a year-over-year change of +15.7%. EPS of $3.98 for the same period compares with $4.20 a year ago. Compared to ...

Have you ever wondered if semen and sperm are the same thing? It’s one of those questions many people hesitate to ask, often because it feels too awkward or 'basic' to bring up. But when you ...

Investors seeking relief from the stock market turbulence at the start of 2025 should take a close look at Vertex Pharmaceuticals (NASDAQ: VRTX). Compared to the S&P 500 index, which is down about ...

Houston will likely have the same ideas, going over ball screens, hard-hedging, blitzing to get the ball out of Clayton's hands and making sure he doesn't get a clean look. -- Jeff Borzello Jeff ...

This is an edition of The Atlantic Daily, a newsletter that guides you through the biggest stories of the day, helps you discover new ideas, and recommends the best in culture. Sign up for it here ...